Sweeting Arianne, MacMillan Freya, Simmons David
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Aust N Z J Obstet Gynaecol. 2024 Oct;64(5):519-523. doi: 10.1111/ajo.13823. Epub 2024 Apr 18.
The first International Association of Diabetes and Pregnancy Study Groups Summit on the diagnosis of gestational diabetes in early pregnancy (Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) Summit) was held on the 17 November 2022 in Sydney, Australia. It sought to use the TOBOGM trial findings to scope the issues involved with early screening, to inform future discussions over possible approaches for diagnosing gestational diabetes mellitus (GDM) in early pregnancy. Most delegates supported testing for early GDM using a one-step 75 g oral glucose tolerance test approach with Canadian Diabetes Association criteria preferred, but highlighted the importance of considering resources, cost, consumer perspectives and equity in translating TOBOGM results into a clinical approach to screening for, and diagnosing, early GDM.
第一届国际糖尿病与妊娠研究组早期妊娠妊娠期糖尿病诊断峰会(妊娠糖尿病预订治疗(TOBOGM)峰会)于2022年11月17日在澳大利亚悉尼举行。该峰会旨在利用TOBOGM试验结果探讨早期筛查所涉及的问题,为未来关于早期妊娠诊断妊娠期糖尿病(GDM)可能方法的讨论提供信息。大多数代表支持采用一步法75克口服葡萄糖耐量试验方法进行早期GDM检测,首选加拿大糖尿病协会标准,但强调在将TOBOGM结果转化为早期GDM筛查和诊断的临床方法时,考虑资源、成本、消费者观点和公平性的重要性。